` SLV (Selvita SA) vs WIG20 Comparison - Alpha Spread

S
SLV
vs
W
WIG20

Over the past 12 months, SLV has underperformed WIG20, delivering a return of -12% compared to the WIG20's +41% growth.

Stocks Performance
SLV vs WIG20

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SLV vs WIG20

Loading
SLV
WIG20
Difference
www.alphaspread.com

Performance By Year
SLV vs WIG20

Loading
SLV
WIG20
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Selvita SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Selvita SA
Glance View

Selvita SA engages in the discovery, regulatory studies, as well as research and development. The company is headquartered in Krakow, Woj. Malopolskie and currently employs 878 full-time employees. The company went IPO on 2019-10-16. The firm is engaged in providing multidisciplinary solutions supporting customers and projects within area of drug discovery, regulatory studies, as well as research and development. The company offers its clients drug discovery support at every stage of the early discovery phase up to preclinical research, from target validation up to the selection of a clinical candidate. Also, it offers services at every stage of the drug discovery process in the field of drug testing and bioanalytical analyses, from development and validation of methods, stability studies, to routine quality control testing. The firm cooperates with numerous research institutes and universities from Europe and the United States.

SLV Intrinsic Value
66.1 PLN
Undervaluation 34%
Intrinsic Value
Price
S
Back to Top